
Sign up to save your podcasts
Or


The US central bank has left interest rates unchanged this month but says they will be cut three times before the end of the year. We look into the details.
The world's most expensive drug will soon be available in the US at a price of $4.25m. We hear about the rare disease it treats and the high cost of developing medicine to battle it.
Sam Fenwick discusses these and more business stories with two guests on opposite sides of the world: Kristina Hooper, Chief Global Market Strategist at New York-based Invesco, and Yoko Ishikura, Professor Emeritus at Hitotsubashi University.
(Picture: US Federal Reserve Board Chairman Jerome Powell. Picture credit: SHAWN THEW/EPA-EFE/REX/Shutterstock.)
By BBC News4.3
4747 ratings
The US central bank has left interest rates unchanged this month but says they will be cut three times before the end of the year. We look into the details.
The world's most expensive drug will soon be available in the US at a price of $4.25m. We hear about the rare disease it treats and the high cost of developing medicine to battle it.
Sam Fenwick discusses these and more business stories with two guests on opposite sides of the world: Kristina Hooper, Chief Global Market Strategist at New York-based Invesco, and Yoko Ishikura, Professor Emeritus at Hitotsubashi University.
(Picture: US Federal Reserve Board Chairman Jerome Powell. Picture credit: SHAWN THEW/EPA-EFE/REX/Shutterstock.)

7,747 Listeners

526 Listeners

1,065 Listeners

304 Listeners

423 Listeners

5,471 Listeners

1,821 Listeners

1,789 Listeners

1,047 Listeners

2,077 Listeners

357 Listeners

200 Listeners

249 Listeners

649 Listeners

227 Listeners

3,221 Listeners

743 Listeners

1,041 Listeners

354 Listeners

47 Listeners

27 Listeners

152 Listeners